Silver nanoparticles in brain tumor targeting

Shinde, Ujwala A.; Warrier, Deepa U.; Bhagwat, Pallavi M.; Vasani, Heta S.; Desai, Harita R.; Singh, Kavita

doi:10.1016/b978-0-323-90773-6.00025-7

Cited by 3 publications

(2 citation statements)

References 78 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With exceptionally improved physicochemical properties, such as catalytic, optical, thermal, and electrical properties, MNPs have bactericidal, antiviral, fungicidal, and antioxidant potential. According to studies, these NPs are also used in a range of biological fields, including drug delivery, cancer treatment, and diagnostics [ 121 ].…”

Section: Inorganic Nanocarriersmentioning

confidence: 99%

“…Fe 3 O 4 MNPs have recently been thoroughly proven to be efficient PTT agents for cancer therapy using near-infrared (NIR) light. However, the mechanism by which Fe 3 O 4 MNPs induce cellular apoptosis has not been extensively analyzed, particularly the effect of an anti-GBM medicine inside cancer cells due to the photothermal effect [ 121 ]. In a pre-clinal study, Cho and associates investigated how Fe 3 O 4 MNPs supported efficient chemo-PPT-induced cell killing in U87-MG brain cancer.…”

Section: Inorganic Nanocarriersmentioning

confidence: 99%

See 1 more Smart Citation

Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier

WADHWA,

CHAUHAN,

KUMAR

et al. 2024

View full text Add to dashboard Cite

Background Glioblastoma multiforme (GBM) is recognized as the most lethal and most highly invasive tumor. The high likelihood of treatment failure arises from the presence of the blood-brain barrier (BBB) and stem cells around GBM, which avert the entry of chemotherapeutic drugs into the tumor mass. Objective Recently, several researchers have designed novel nanocarrier systems like liposomes, dendrimers, metallic nanoparticles, nanodiamonds, and nanorobot approaches, allowing drugs to infiltrate the BBB more efficiently, opening up innovative avenues to prevail over therapy problems and radiation therapy. Methods Relevant literature for this manuscript has been collected from a comprehensive and systematic search of databases, for example, PubMed, Science Direct, Google Scholar, and others, using specific keyword combinations, including “glioblastoma,” “brain tumor,” “nanocarriers,” and several others. Conclusion This review also provides deep insights into recent advancements in nanocarrier-based formulations and technologies for GBM management. Elucidation of various scientific advances in conjunction with encouraging findings concerning the future perspectives and challenges of nanocarriers for effective brain tumor management has also been discussed.

show abstract

Section: Inorganic Nanocarriersmentioning

confidence: 99%

Section: Inorganic Nanocarriersmentioning

confidence: 99%